Pharmacological treatment can be cost-effective
A systematic review of pharmacological treatment in primary care (orlistat, sibutramine and rimonabant– the latter two now withdrawn) has shown all were effective at reducing weight and BMI, and cost effective when using a threshold of £20,000 per QALY.
Immediately related elementsHow this works
-
Tackling obesity in the UK »Tackling obesity in the UK
Tackling obesity »Tackling obesity
Develop a coherent fiscal, regulatory and governance framework »Develop a coherent fiscal, regulatory and governance framework
Invest in weight management services »Invest in weight management services
Improve support for people with severe and complicated obesity »Improve support for people with severe and complicated obesity
Pharmacological treatment can be cost-effective
+Kommentare (0)
+Verweise (1)
+About